Precision point-of-care in drug delivery: empowering innovations with optical fiber assisted by microfluidics

T. M. Caputo; A. Aliberti; A. M. Cusano; C. Mule; A. Micco; A. Cusano

doi:10.1117/12.3017073

20 June 2024 Precision point-of-care in drug delivery: empowering innovations with optical fiber assisted by microfluidics

T. M. Caputo, A. Aliberti, A. M. Cusano, C. Mule, A. Micco, A. Cusano

Author Affiliations +

Proceedings Volume 13008, Biophotonics in Point-of-Care III; 130080J (2024) https://doi.org/10.1117/12.3017073
Event: SPIE Photonics Europe, 2024, Strasbourg, France

Abstract

Recent advancements in loco-regional therapy are revolutionizing the point-of-care (POC) drug delivery field, enhancing the convenience, comfort, and effectiveness of these devices for patients. New anticancer drugs have improved the therapy, but there is still significant work to be done in order to selectively target tumour cells. To bridge this gap, here, we present a minimally invasive tool based on optical fibers (OFs) integrated in a microfluidic device for light-triggered loco regional delivery of drug-loaded particles. Specifically, we, here, selected the Lab on Fiber (LOF) technology as an attractive option to guide light and trigger the drug release. LOF, indeed, enables precise drug dosing and targeted transport, laying the foundation for mini-invasive platforms in light-activated loco-regional drug delivery. The platform includes drug-loaded carriers covalently attached on the OF surface through a photocleavable linker. The OF platform has been designed to spread light from the core region towards the cladding area in order to achieve enough power density to photo-cleave the linker and release the carrier. To this aim, side-emitting and core-offset OFs optrodes have been designed, fabricated and characterized achieving power density and scattering efficiency of 30% and 5mW/cm² and 24.9% and 4.64mW/cm². OFs were integrated into a microfluidic device and the particle release upon light activation was quantified. The side-emitting OF microfluidic system, designed for Hepatocellular cancer therapy, released 2.60μg/ml of carriers, while the core-offset OF microfluidic system, for Breast cancer treatment, released 1.06μg/ml of carriers. This approach holds potential for improving cancer treatment outcomes

Conference Presentation

(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.

Citation Download Citation

T. M. Caputo, A. Aliberti, A. M. Cusano, C. Mule, A. Micco, and A. Cusano "Precision point-of-care in drug delivery: empowering innovations with optical fiber assisted by microfluidics", Proc. SPIE 13008, Biophotonics in Point-of-Care III, 130080J (20 June 2024); https://doi.org/10.1117/12.3017073

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available